{"text": ["The", "March", "to", "Freedom", "Fund", "2nd-Quarter", "Review"], "created_at": "2020-07-07 19:42:21"}
{"text": ["5", "Companies", "Reach", "52-Week", "Highs"], "created_at": "2020-07-07 15:40:04"}
{"text": ["Top", "Ranked", "Value", "Stocks", "to", "Buy", "for", "July", "7th"], "created_at": "2020-07-07 14:13:02"}
{"text": ["4", "Value", "Stocks", "to", "Buy", "in", "a", "Recovering", "Economy"], "created_at": "2020-07-07 12:53:12"}
{"text": ["AbbVie", "to", "Host", "Second-Quarter", "2020", "Earnings", "Conference", "Call"], "created_at": "2020-07-07 12:00:00"}
{"text": ["3", "Best-Performing", "Dividend", "Aristocrats", "in", "the", "First", "Half", "of", "2020:", "Are", "They", "Buys", "Now?"], "created_at": "2020-07-07 10:41:00"}
{"text": ["Shareholders", "Of", "AbbVie", "(NYSE:ABBV)", "Must", "Be", "Happy", "With", "Their", "75%", "Return"], "created_at": "2020-07-07 10:33:51"}
